Adherence to hypertension and dyslipidemia therapy

Journal of Clinical Outcomes Management

Volumn 12, Issue 7, 2005, Pages 343-344

  Horng, Mark S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; DYSLIPIDEMIA; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HYPERTENSION; MANAGED CARE; MEDICAL RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; SHORT SURVEY; TREATMENT PLANNING; TREATMENT REFUSAL;

EID: 23644432658     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005;293:1868-74.
2. Wong ND, Pio JR, Franklin SS, et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol 2003;91: 1421-6.
3. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-62.